| Literature DB >> 30014747 |
Jaanika Kumm1, Aleksandra Turkiewicz2, Fan Zhang2, Martin Englund2,3.
Abstract
Background and purpose - Few data are available regarding structural changes present in knees without radiographically evident osteoarthritis (OA). We evaluated the prevalence of findings suggestive of knee OA by magnetic resonance imaging (MRI) in middle-aged subjects without radiographic OA with or without OA risk factors. Patients and methods - 340 subjects from the Osteoarthritis Initiative, aged 45-55 years (51% women) with Kellgren-Lawrence grade 0 in both knees, who had 3T knee MR images were eligible. 294 subjects had risk factors and 46 were without risk factors. MR images were assessed using the MOAKS scoring system. Results - At least 1 MR-detected feature was found in 96% (283/294) of subjects with risk factors and in 87% (40/46) of those without. Cartilage damage (82%), bone marrow lesions (60%), osteophytes (45%), meniscal body extrusion (32%), and synovitis-effusion (29%) were the most common findings in subjects with risk factors, while cartilage damage (67%), osteophytes (46%), meniscal body extrusion (37%), and bone marrow lesions (35%) were most common in subjects without. The prevalence of any abnormality was higher in subjects with OA risk factors than in subjects without (prevalence ratio adjusted for age and sex 1.3 [95% CI 1.1-1.6]), so was prevalence of subchondral cysts and bone marrow lesions. MR-detected structural changes were more frequent in patellofemoral joints. Interpretation - Our findings highlight the great challenge in distinguishing pathological features of early knee OA from what could be considered part of "normal ageing." Bone marrow lesions were more frequently found in subjects with multiple OA risk factors.Entities:
Mesh:
Year: 2018 PMID: 30014747 PMCID: PMC6202768 DOI: 10.1080/17453674.2018.1495164
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Characteristics of the study participants. Values are frequency and (percentage) unless otherwise stated
| Subjects with OA risk factors (n = 294) | Reference cohort (n = 46) | |
|---|---|---|
| Age, mean (SD) | 50 (2.9) | 50 (3.3) |
| Women | 146 (50) | 27 (59) |
| BMI a: | ||
| < 25 | 104 (35) | 26 (57) |
| 25–29 | 114 (39) | 20 (44) |
| ≥ 30 | 70 (24) | 0 (0) |
| Family history of joint replacement | 53 (18) | 0 (0) |
| Heberden’s nodes, either hand | 55 (19) | 2 (4) |
| Engage in at least 1 knee bending activity | 203 (69) | 19 (41) |
| Knee symptoms (pain, aching, or stiffness), either knee | 273 (93) | 0 (0) |
Data on BMI (body mass index) is missing for 6 individuals.
As assessed in eligibility interviews at baseline.
Prevalence of MRI structural abnormalities in the right knees of the study subjects with knee OA risk factors. Values are frequency and (percentage)
| MRI feature | Overall (n = 294) | Women (n = 146) | Men (n = 148) | BMI a | ||
|---|---|---|---|---|---|---|
| < 25 (n = 104) | 25–29 (n = 114) | ≥ 30 (n = 70) | ||||
| Cartilage damage | 240 (82) | 125 (86) | 115 (78) | 80 (77) | 94 (82) | 61 (87) |
| Tibiofemoral | 189 (64) | 90 (62) | 99 (67) | 65 (63) | 70 (61) | 49 (70) |
| Tibiofemoral medial | 120 (41) | 55 (38) | 65 (44) | 48 (46) | 46 (40) | 23 (33) |
| Tibiofemoral lateral | 127 (43) | 60 (41) | 67 (45) | 43 (41) | 45 (39) | 34 (49) |
| Patellofemoral | 199 (68) | 109 (75) | 90 (61) | 64 (62) | 80 (70) | 52 (74) |
| Osteophytes | 131 (45) | 56 (38) | 75 (51) | 35 (34) | 58 (51) | 36 (51) |
| Tibiofemoral | 56 (19) | 28 (19) | 28 (19) | 21 (20) | 20 (18) | 14 (20) |
| Tibiofemoral medial | 43 (15) | 21 (14) | 22 (15) | 17 (16) | 13 (11) | 12 (17) |
| Tibiofemoral lateral | 30 (10) | 15 (10) | 15 (10) | 9 (9) | 11 (10) | 9 (13) |
| Patellofemoral | 124 (42) | 52 (36) | 72 (49) | 33 (32) | 54 (47) | 35 (50) |
| Bone marrow lesions | 176 (60) | 91 (62) | 85 (57) | 59 (57) | 64 (56) | 49 (70) |
| Tibiofemoral | 91 (31) | 40 (27) | 51 (34) | 34 (33) | 32 (28) | 22 (31) |
| Tibiofemoral medial | 54 (18) | 23 (16) | 31 (21) | 24 (23) | 17 (15) | 13 (19) |
| Tibiofemoral lateral | 43 (15) | 18 (12) | 25 (17) | 11 (11) | 18 (16) | 11 (16) |
| Patellofemoral | 138 (47) | 75 (51) | 63 (43) | 43 (41) | 56 (49) | 38 (54) |
| Subchondral cysts | 119 (40) | 67 (46) | 52 (35) | 38 (37) | 46 (40) | 32 (46) |
| Tibiofemoral | 51 (17) | 24 (16) | 27 (18) | 17 (16) | 19 (17) | 13 (19) |
| Tibiofemoral medial | 31 (11) | 14 (10) | 17 (11) | 12 (12) | 10 (9) | 9 (13) |
| Tibiofemoral lateral | 22 (8) | 10 (7) | 12 (8) | 5 (5) | 10 (9) | 5 (7) |
| Patellofemoral | 93 (32) | 55 (38) | 38 (26) | 28 (27) | 40 (35) | 24 (34) |
| Meniscal damage | 55 (19) | 20 (14) | 35 (24) | 25 (24) | 17 (15) | 9 (13) |
| Meniscal extrusion | 68 (23) | 32 (22) | 36 (24) | 21 (20) | 31 (27) | 14 (20) |
| Synovitis effusion | 86 (29) | 38 (26) | 48 (32) | 30 (29) | 31 (27) | 23 (33) |
| Hoffa synovitis | 130 (44) | 58 (40) | 72 (49) | 48 (46) | 48 (42) | 32 (46) |
| Popliteal cysts | 83 (28) | 42 (29) | 41 (28) | 33 (32) | 32 (28) | 16 (23) |
Data on BMI is missing for 6 individuals.
Prevalence of MRI structural abnormalities in the right knees of the study subjects without knee OA risk factors (reference cohort). Values are frequency and (percentage)
| MRI feature | Overall (n = 46) | Women (n = 27) | Men (n = 19) | BMI | |
|---|---|---|---|---|---|
| < 25 (n = 26) | 25–29 (n = 20) | ||||
| Cartilage damage | 31 (67) | 21 (78) | 10 (53) | 18 (69) | 13 (65) |
| Tibiofemoral | 21 (46) | 15 (56) | 6 (32) | 13 (50) | 8 (40) |
| Tibiofemoral medial | 15 (33) | 12 (44) | 3 (16) | 10 (38) | 5 (25) |
| Tibiofemoral lateral | 11 (24) | 8 (30) | 3 (16) | 6 (23) | 5 (25) |
| Patellofemoral | 26 (57) | 19 (70) | 7 (37) | 16 (62) | 10 (50) |
| Osteophytes | 21 (46) | 14 (52) | 7 (37) | 11 (42) | 10 (50) |
| Tibiofemoral | 5 (11) | 4 (15) | 1 (5) | 4 (15) | 1 (5) |
| Tibiofemoral medial | 4 (9) | 3 (11) | 1 (5) | 3 (12) | 1 (5) |
| Tibiofemoral lateral | 1 (2) | 1 (4) | 0 (0) | 1 (4) | 0 (0) |
| Patellofemoral | 20 (43) | 13 (48) | 7 (37) | 10 (38) | 10 (50) |
| Bone marrow lesions | 16 (35) | 9 (33) | 7 (37) | 9 (35) | 7 (35) |
| Tibiofemoral | 5 (11) | 3 (11) | 2 (11) | 3 (12) | 2 (10) |
| Tibiofemoral medial | 2 (4) | 1 (4) | 1 (5) | 1 (4) | 1 (5) |
| Tibiofemoral lateral | 3 (7) | 2 (7) | 1 (5) | 2 (8) | 1 (5) |
| Patellofemoral | 14 (30) | 8 (30) | 6 (32) | 8 (31) | 6 (30) |
| Subchondral cysts | 9 (20) | 7 (26) | 2 (11) | 7 (27) | 2 (10) |
| Tibiofemoral | 3 (7) | 3 (11) | 0 (0) | 3 (12) | 0 (0) |
| Tibiofemoral medial | 1 (2) | 1 (4) | 0 (0) | 1 (4) | 0 (0) |
| Tibiofemoral lateral | 2 (4) | 2 (7) | 0 (0) | 2 (8) | 0 (0) |
| Patellofemoral | 6 (13) | 4 (15) | 2 (11) | 4 (15) | 2 (10) |
| Meniscal damage | 5 (11) | 2 (7) | 3 (16) | 2(8) | 3 (15) |
| Meniscal extrusion | 10 (22) | 4 (15) | 6 (32) | 6 (23) | 4 (20) |
| Synovitis effusion | 8 (17) | 7 (26) | 1 (5) | 4 (15) | 4 (20) |
| Hoffa synovitis | 14 (30) | 8 (30) | 6 (32) | 10 (38) | 4 (20) |
| Popliteal cysts | 12 (26) | 7 (26) | 5 (26) | 7 (27) | 5 (25) |